J. Genescà

M. Buti, T. Pumarola, C. Perales, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

R. Bataller, F. Jorquera, M. Diago, 2019, Gastroenterologia y hepatologia.

R. Bataller, F. Jorquera, M. Diago, 2019, Gastroenterología y Hepatología (English Edition).

Disappearance of serum hepatitis B virus DNA by polymerase chain reaction after adenine arabinoside 5'-monophosphate therapy in chronic hepatitis B.

M. Buti, J. Genescà, R. Esteban, 2008, Liver.

Interferon‐α in acute posttransfusion hepatitis C:. A randomized, controlled trial

J. Esteban, J. Genescà, R. Esteban, 1992 .

Clinical and serological outcome of acute delta infection.

M. Buti, J. Esteban, J. Genescà, 1987, Journal of hepatology.

Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals

J. Genescà, R. Esteban, M. Riveiro-Barciela, 2017, Therapeutic advances in gastroenterology.

HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN

M. Buti, M. Houghton, Q. Choo, 1989, The Lancet.

High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.

J. Esteban, J. Genescà, R. Esteban, 1991, Annals of internal medicine.

Clinical correlation and genetic polymorphism of the human immunodeficiency virus proviral DNA obtained after polymerase chain reaction amplification.

J. Genescà, H. Alter, J. Shih, 1990, The Journal of infectious diseases.

Blood-Borne Non-A, Non-B Hepatitis: Hepatitis C

J. Esteban, J. Genescà, H. Alter, 1991, Seminars in liver disease.

Acute esophageal variceal bleeding: Current strategies and new perspectives.

J. Genescà, António Gonzalez, S. Augustin, 2010, World journal of hepatology.

Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.

J. Bosch, J. Calleja, J. García‐Pagán, 2016, Gastroenterology.

Identifying Compensated Advanced Chronic Liver Disease: When (Not) to Start Screening for Varices and Clinically Significant Portal Hypertension

J. Genescà, S. Augustin, M. Pons, 2016 .

The renal effects of droxidopa are maintained in propranolol treated cirrhotic rats

Nahia Ezkurdia, M. Martell, J. Genescà, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Effectiveness of Combined Pharmacologic and Ligation Therapy in High-Risk Patients With Acute Esophageal Variceal Bleeding

F. Azpiroz, J. Altamirano, J. Genescà, 2011, The American Journal of Gastroenterology.

Hemodynamic response–guided therapy for prevention of variceal rebleeding: An uncontrolled pilot study

J. Genescà, R. Esteban, A. Tomasello, 2006, Hepatology.

Adding banding ligation is effective as rescue therapy to prevent variceal rebleeding in haemodynamic non-responders to pharmacological therapy.

J. Genescà, R. Esteban, J. Dot, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis.

Joan Genescà, J. Altamirano, J. Genescà, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study

M. Rudler, D. Thabut, F. Nevens, 2018, Hepatology.

Alcohol consumption and risk of infection after a variceal bleeding in low‐risk patients

J. Genescà, R. Esteban, António Gonzalez, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon.

E. Bonifacio, R. Simó, M. Puig-Domingo, 2001, The Journal of laboratory and clinical medicine.

Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis

C. Manichanh, A. Santiago, M. Martell, 2018, Hepatology.

Simvastatin-loaded polymeric micelles are more effective and less toxic than conventional statins in a pre-clinical model of advanced chronic liver disease.

S. Schwartz, D. Rafael, M. Martell, 2020, Nanomedicine : nanotechnology, biology, and medicine.

A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo

D. Gottardi, S. Possemiers, M. Martell, 2022, Biomedicines.

Soluble Interleukin-6 Receptor Levels in Liver Cirrhosis

J. Genescà, António Gonzalez, Mireia Torregrosa, 1999, American Journal of Gastroenterology.

Familial amyloidosis in a large Spanish kindred resulting from a D38V mutation in the transthyretin gene

A. Andreu, J. Genescà, S. Augustin, 2007, European journal of clinical investigation.

ROLE OF DOPPLER ECHOCARDIOGRAPHY IN THE ASSESSMENT OF PORTOPULMONARY HYPERTENSION IN LIVER TRANSPLANTATION CANDIDATES1

A. Evangelista, C. Margarit, J. Genescà, 2001, Transplantation.

Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis

M. Poca, J. Calleja, J. Genescà, 2021, Journal of clinical medicine.

University of Southern Denmark Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation Hamesch,

Ravi, C. Trautwein, Malin, 2019 .

Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.

M. Mejías, J. Bosch, M. Martell, 2008, Journal of hepatology.

Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis.

M. Kumar, P. Hayes, M. Poca, 2022, Journal of hepatology.

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

M. Poca, J. Calleja, J. Genescà, 2019, The Lancet.

Development of hyperdynamic circulation and response to β‐blockers in compensated cirrhosis with portal hypertension

M. Poca, J. Calleja, J. Genescà, 2016, Hepatology.

Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats

Nahia Ezkurdia, M. Martell, J. Genescà, 2012, Hepatology.

Blockage of the afferent sensitive pathway prevents sympathetic atrophy and hemodynamic alterations in rat portal hypertension

Nahia Ezkurdia, M. Martell, J. Genescà, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory

M. Miravitlles, C. Esquinas, A. Núñez, 2020, International journal of chronic obstructive pulmonary disease.

Spontaneous portosystemic shunts in liver cirrhosis: new approaches to an old problem

J. Genescà, M. Simón-Talero, S. Quiroga, 2020, Therapeutic advances in gastroenterology.

Increased tumour necrosis factor α production in mesenteric lymph nodes of cirrhotic patients with ascites

C. Margarit, F. Rojo, J. Genescà, 2003, Gut.

Covert hepatic encephalopathy and spontaneous portosystemic shunts increase the risk of developing overt hepatic encephalopathy

A. Wienke, J. Trebicka, J. Genescà, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Nitric oxide may contribute to nocturnal hemodynamic changes in cirrhotic patients.

Miguel Ángel Martínez, J. Genescà, R. Esteban, 2000 .

Nitric oxide may contribute to nocturnal hemodynamic changes in cirrhotic patients

J. Genescà, R. Esteban, R. Catalán, 2000, American Journal of Gastroenterology.

Inhibition of Neuronal Apoptosis and Axonal Regression Ameliorates Sympathetic Atrophy and Hemodynamic Alterations in Portal Hypertensive Rats

Nahia Ezkurdia, M. Martell, J. Genescà, 2014, PloS one.

Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension

Nahia Ezkurdia, J. Hernández-Losa, M. Martell, 2010, Liver international : official journal of the International Association for the Study of the Liver.

High Levels of Endotoxin Antibodies Contribute to Hyperglobulinemia of Cirrhotic Patients

J. Genescà, António Gonzalez, A. Mujal, 1998, American Journal of Gastroenterology.

Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes: A retrospective case-control study

A. Ciudin, J. Genescà, J. Pericàs, 2022, Frontiers in Endocrinology.

J. Bosch, J. Genescà, C. Ripoll, 2014 .

Reply: To PMID 23908019.

J. Bosch, J. Genescà, C. Ripoll, 2014, Hepatology.

Hepatitis C: molecular biology, pathogenesis, epidemiology, clinical features, and prevention.

J. Esteban, J. Genescà, H. Alter, 1992, Progress in liver diseases.

HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease.

M. Trauner, P. Ferenci, E. Meyer, 2021, Journal of hepatology.

Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.

B. Colsch, C. Junot, F. Nevens, 2019, Journal of hepatology.

Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis.

M. Rudler, D. Thabut, F. Nevens, 2021, Journal of hepatology.

Steatosis as main determinant of portal hypertension through a restriction of hepatic sinusoidal area in a dietary rat nash model

M. Martell, J. Genescà, M. Bravo, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Beyond Baveno VI: How far are we?

J. Genescà, M. Pons, Joan Martínez-Campreciós, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease

J. Bosch, C. Bureau, E. Tsochatzis, 2017, Hepatology.

Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.

M. Martell, J. Genescà, R. Esteban, 2014, Journal of hepatology.

Elastography methods for the non-invasive assessment of portal hypertension

E. Tsochatzis, J. Genescà, D. Roccarina, 2018, Expert review of gastroenterology & hepatology.

Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

M. Rudler, D. Thabut, F. Nevens, 2022, Gut.

Effect of rifaximin on infections, acute‐on‐chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA‐AH)

R. Schwabe, R. Bataller, M. Poca, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Risk Stratification with Noninvasive Tools in Patients with Compensated Cirrhosis

J. Genescà, S. Augustin, M. Pons, 2017, Current Hepatology Reports.

Reply to "Points to be considered when using transient elastography for diagnosis of portal hypertension according to the Baveno's VI consensus".

M. Pinzani, A. Berzigotti, J. Genescà, 2015, Journal of hepatology.

Predicting 6-week mortality after acute variceal bleeding: role of Classification and Regression Tree analysis.

J. Altamirano, J. Genescà, L. Zapata, 2009, Annals of hepatology.

Propranolol plus placebo versus propranolol plus isosorbide‐5‐mononitrate in the prevention of a first variceal bleed: A double‐blind RCT

J. Calleja, J. García‐Pagán, J. Genescà, 2003, Hepatology.

Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers.

J. Calleja, J. García‐Pagán, J. Genescà, 2001, Gastroenterology.

Basal values and changes of liver stiffness predict the risk of disease progression in compensated advanced chronic liver disease.

J. Genescà, S. Augustin, M. Pons, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study

F. Nevens, S. Sarin, D. Valla, 2020, Hepatology.

Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.

M. Rudler, D. Thabut, F. Nevens, 2020, Journal of hepatology.

WHEN SHOULD AT-RISK INFANTS BE BOOSTED WITH HEPATITIS B VACCINE?

J. Esteban, J. Genescà, R. Esteban, 1987, The Lancet.

Non-invasive prediction of liver related events in HCV compensated advanced chronic liver disease patients after oral antivirals.

M. Buti, X. Forns, J. Esteban, 2020, Journal of hepatology.

Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and Cons.

F. Tacke, F. Koenig, E. Meyer, 2022, Journal of hepatology.

Hepatitis b virus replication in acute hepatitis B, acute hepatitis B virus‐hepatitis delta virus coinfection and acute hepatitis delta superinfection

M. Buti, J. Esteban, J. Genescà, 1987, Hepatology.

[Relationship between iron stores and diabetes mellitus in patients infected by hepatitis C virus: a case-control study].

R. Simó, C. Hernández, J. Genescà, 2000, Medicina clinica.

Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model

J. Chan, A. Rabiee, M. Ciarleglio, 2022, Hepatology communications.

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.

J. Bosch, C. Bureau, E. Tsochatzis, 2020, The American journal of gastroenterology.

Validation of Automated Blood Cell Counters for the Diagnosis of Spontaneous Bacterial Peritonitis

J. Genescà, R. Segura, F. Cereto, 2004, American Journal of Gastroenterology.

Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis

J. Genescà, G. Prats, M. Simó, 2008, European journal of gastroenterology & hepatology.

Role of immunosuppression in the development of quinolone‐resistant Escherichia coli spontaneous bacterial peritonitis and in the mortality of E. coli spontaneous bacterial peritonitis

J. Genescà, R. Esteban, J. Guàrdia, 2003, Alimentary pharmacology & therapeutics.

Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication.

S. Sauleda, J. Vila, J. Esteban, 1995, Journal of hepatology.

Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis.

R. Groszmann, B. Sharma, S. Sarin, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[Hepatic angiomyolipoma in two patients infected with hepatitis C virus].

I. Bilbao, C. Margarit, J. Genescà, 2007, Gastroenterologia y hepatologia.

Hepatitis C Virus(HCV)Circulates as a Population ofDifferent butClosely Related Genomes:Quasispecies Nature ofHCV GenomeDistribution

A. Weiner, M. Martell, J. Genescà, 1992 .

A MELD-based model to determine risk of mortality among patients with acute variceal bleeding.

P. Tandon, A. Berzigotti, J. Genescà, 2014, Gastroenterology.

Understanding the inhibiting properties of 3-amino-1,2,4-triazole from fractal analysis

E. García-Ochoa, J. Genescà, 2004 .

Experimental and theoretical study of 1-(2-ethylamino)-2-methylimidazoline as an inhibitor of carbon steel corrosion in acid media

E. García-Ochoa, J. Genescà, J. Cruz, 2004 .

What do western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors?

I. Hewlett, J. Epstein, J. Genescà, 1989, Lancet.

Long‐term follow‐up of hemodynamic responders to pharmacological therapy after variceal bleeding

M. Martell, J. Genescà, R. Esteban, 2012, Hepatology.

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.

J. Bosch, C. Bureau, E. Tsochatzis, 2021, The American journal of gastroenterology.

Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study

J. Bosch, C. Bureau, A. Berzigotti, 2016, Hepatology.

Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.

Zaibo Jiang, M. Rudler, D. Thabut, 2020, Gastroenterology.

Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.

R. Bataller, J. Muntané, F. Jorquera, 2018 .

Cytochemical studies on the nature of NOR (nucleolus organizer region) silver stainability.

E. Querol, J. Genescà, J. Egozcue, 1983, Cellular and molecular biology.

Glucose Abnormalities in Patients with Hepatitis C Virus Infection

R. Simó, A. Lecube, C. Hernández, 2006, Diabetes Care.

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

J. Mateo, A. Berzigotti, J. García‐Pagán, 2017 .

[Portal hypertension: recommendations for evaluation and treatment: consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Center for Liver and Digestive Diseases(CIBERehd)].

J. Calleja, A. Berzigotti, J. García‐Pagán, 2012, Gastroenterologia y hepatologia.

Immunoprophylaxis of perinatal transmission of the hepatitis B virus: Efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low‐prevalence area

M. Buti, J. Esteban, J. Genescà, 1986, Journal of medical virology.

Baveno VII - Renewing consensus in portal hypertension.

H. Yoshiji, J. Fallowfield, V. Paradis, 2021, Journal of hepatology.

Physiopathology of splanchnic vasodilation in portal hypertension.

Nahia Ezkurdia, M. Martell, J. Genescà, 2010, World journal of hepatology.

WHAT DO WESTERN BLOT INDETERMINATE PATTERNS FOR HUMAN IMMUNODEFICIENCY VIRUS MEAN IN EIA-NEGATIVE BLOOD DONORS?

I. Hewlett, J. Epstein, J. Genescà, 1989, The Lancet.

High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry

X. Qi, E. Barnes, R. Dhanasekaran, 2020, Journal of Hepatology.

Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency

C. Trautwein, F. Lammert, D. Lomas, 2021, Gut.

High Prevalence of Hepatitis C Virus Infection in Diabetic Patients

R. Simó, C. Hernández, J. Genescà, 1996, Diabetes Care.

Response to Heish et al.

R. Simó, A. Lecube, C. Hernández, 2008, The American Journal of Gastroenterology.

Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.

C. Strassburg, D. Toth, J. Trebicka, 2020, Journal of hepatology.

Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.

D. Toth, J. Trebicka, W. Laleman, 2018, Gastroenterology.

Structure of replicating hepatitis C virus (HCV) quasispecies in the liver may not be reflected by analysis of circulating HCV virions

M. Martell, J. Esteban, J. Genescà, 1997, Journal of virology.

Impact of anticoagulation on upper‐gastrointestinal bleeding in cirrhosis. A retrospective multicenter study

M. Casas, J. García‐Pagán, J. Genescà, 2015, Hepatology.

Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis

R. Groszmann, G. Cadelina, J. Genescà, 1999, American Journal of Gastroenterology.

Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study

J. Montaner, R. Simó, J. Rodríguez-Palomares, 2019, BMJ Open Diabetes Research & Care.

Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

A. de Gottardi, F. Nevens, J. Trebicka, 2022, Transplantation.

High doses of β‐blockers and alcohol abstinence improve long‐term rebleeding and mortality in cirrhotic patients after an acute variceal bleeding

J. Altamirano, J. Genescà, R. Esteban, 2010, Liver international : official journal of the International Association for the Study of the Liver.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis

M. Poca, J. Falcón-Pérez, J. Bosch, 2021, JHEP reports : innovation in hepatology.

The assessment of natural atmosphere corrosivity by the use of electrochemical noise analysis

E. García-Ochoa, J. Genescà, F. Rodríguez-Gómez, 2006 .

Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH

M. Martell, J. Genescà, M. Bravo, 2021, Disease models & mechanisms.

Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis

A. Montano‐Loza, D. Thorburn, F. Saffioti, 2018, The American Journal of Gastroenterology.

Cerebellar neurodegeneration in a new rat model of episodic hepatic encephalopathy

M. Vila, J. Genescà, J. Córdoba, 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients

J. Ampuero, I. Carmona, J. Genescà, 2017, Therapeutic advances in gastroenterology.

Lack of HIV transmission after hepatitis B immunoprophylaxis

J. Esteban, J. Genescà, R. Esteban, 2005, Infection.

Copper Corrosion Under Non-uniform Magnetic Field in 0.5 M Hydrochloric Acid

E. García-Ochoa, F. Corvo, J. Genescà, 2017, Journal of Materials Engineering and Performance.

Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)

C. Trautwein, T. Berg, C. Junot, 2023, Gut.

Association between circulating alpha-1 antitrypsin polymers and lung and liver disease

M. Miravitlles, C. Esquinas, A. Núñez, 2021, Respiratory Research.

Multicenter External Validation of Risk Stratification Criteria for Patients With Variceal Bleeding

P. Tandon, J. Genescà, J. Abraldes, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Glucose Abnormalities Are an Independent Risk Factor for Nonresponse to Antiviral Treatment in Chronic Hepatitis C

R. Simó, A. Lecube, C. Hernández, 2007, The American Journal of Gastroenterology.

Proinflammatory Cytokines, Insulin Resistance, and Insulin Secretion in Chronic Hepatitis C patients

R. Simó, A. Lecube, C. Hernández, 2006, Diabetes Care.

Clinical, histological and molecular profiling of different stages of alcohol-related liver disease

M. Ziol, C. Sempoux, J. Woosley, 2022, Gut.

Numerical simulation of the aluminum–zinc–steel galvanic system for new designs of automotive chassis

Jaime Taha‐Tijerina, J. Genescà, R. Mayen‐Mondragon, 2019, Materials and Corrosion.

Evaluation and treatment of the critically ill cirrhotic patient

J. Genescà, Javier Fernández, G. Soriano, 2016 .

[Evaluation and treatment of the critically ill cirrhotic patient].

J. Genescà, Javier Fernández, G. Soriano, 2016, Gastroenterologia y hepatologia.

Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH

M. Martell, J. Genescà, M. Bravo, 2019, Scientific Reports.

Evaluation of atmospheric corrosion in Orizaba, Mexico

J. Genescà, J. Uruchurtu-Chavarín, J. L. Ramírez-Reyes, 2012 .

Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case‐control study

J. Bosch, I. Araujo, J. Genescà, 2013, Hepatology.

Interferon-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial.

J. Esteban, J. Genescà, R. Esteban, 1992, Hepatology.

Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis

M. Poca, J. Calleja, J. Lozano, 2023, Hepatology.

α1 and α2‐adrenergic agonists on cirrhotic patients with refractory ascites

J. Genescà, M. Ventura-Cots, B. Santos, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Validating the Baveno VI recommendations for screening varices.

J. Genescà, S. Augustin, M. Pons, 2017, Journal of hepatology.

Risk Stratification in Acute Variceal Bleeding: Child-Pugh Versus Model for End-stage Liver Disease.

J. Genescà, E. Reverter, J. Abraldes, 2017, Journal of clinical gastroenterology.

Do we need to re-define the Baveno VI elastography criteria for compensated advanced chronic liver disease (cACLD)?

J. Bosch, J. Genescà, J. Abraldes, 2021 .

A randomized controlled trial of α-interferon in acute postransfusion C hepatitis

I. Caragol, J. Esteban, J. Genescà, 1990 .

The role of liver steatosis as measured with transient elastography and transaminases on hard clinical outcomes in patients with COVID-19

A. Ciudin, C. Malagelada, J. Genescà, 2021, Therapeutic advances in gastroenterology.

A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats

M. Martell, J. Genescà, Teresa Garcia-Lezana, 2017, Scientific Reports.

M. Rudler, D. Thabut, F. Nevens, 2023, Liver international : official journal of the International Association for the Study of the Liver.

O167 ADDITION OF SIMVASTATIN TO STANDARD TREATMENT IMPROVES SURVIVAL AFTER VARICEAL BLEEDING IN PATIENTS WITH CIRRHOSIS. A DOUBLE-BLIND RANDOMIZED TRIAL (NCT01095185)

J. Bosch, J. Calleja, J. Genescà, 2014 .

O017A : Non-invasive tools and risk of varices and clinically significant portal hypertension in compensated cirrhosis: the “anticipate” study

A. Berzigotti, J. Genescà, H. Stefanescu, 2015 .

Review article: The need for more efficient and patient‐oriented drug development pathways in NASH—setting the scene for platform trials

F. Tacke, Q. Anstee, J. Genescà, 2023, Alimentary Pharmacology and Therapeutics.

Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial

P. Hayes, Ferran Torres, J. Genescà, 2023, Hepatology.

Prognostic Evaluation of Patients with Acute Variceal Bleeding

M. Martell, J. Genescà, António Gonzalez, 2011, Disease markers.

Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica

J. Muntané, F. Jorquera, M. Diago, 2018 .

Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial

J. Ampuero, G. Casanovas, J. Genescà, 2023, Journal of Hepatology.

Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b.

J. Esteban, J. Quer, J. Genescà, 1993, Gut.

University of Birmingham Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency

Frederik, C. Trautwein, F. Lammert, 2022 .

Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica

J. Muntané, F. Jorquera, M. Diago, 2018 .

Elastography methods for the non-invasive assessment of portal hypertension

E. Tsochatzis, J. Genescà, D. Roccarina, 2018, Expert review of gastroenterology & hepatology.

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

J. Mateo, J. García‐Pagán, J. Genescà, 2017, Gastroenterologia y hepatologia.

Enfermedad hepática por alcohol. Guías de práctica clínica. Documento de consenso auspiciado por la AEEH

R. Bataller, F. Jorquera, M. Diago, 2019, Gastroenterología y Hepatología.

Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study

J. Bosch, C. Bureau, A. Berzigotti, 2016, Hepatology.

Proteomic Analysis of Dysfunctional Liver Sinusoidal Endothelial Cells Reveals Substantial Differences in Most Common Experimental Models of Chronic Liver Diseases

M. Azkargorta, F. Elortza, M. Martell, 2023, International journal of molecular sciences.

Preemptive-TIPS improves outcome in high-risk variceal bleeding An observational study

M. Rudler, D. Thabut, F. Nevens, 2018 .